Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

BIOMS Medical Corp: Premium Company Profile

Published by: Datamonitor

Published: Apr. 22, 2008 - 35 Pages


Table of Contents


Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Products & Services
Pipeline Products
AC Forecast Product Sales
Competitors and Strategic Business Relationships
Key Competitors
Key Suppliers
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Product Development
Scorecard
Overview
Scorecard Analysis
Key Employees
List of Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
APPENDIX
Ask the analyst
Datamonitor consulting
Disclaimer
TABLE OF FIGURES
Figure 1: BioMS Medical- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
TABLE OF TABLES
Table 1: BioMS Medical- Key Facts
Table 2: BioMS Medical- Year-End Share Price and Market Capitalization, 2002-2006 (CAD$)
Table 3: BioMS Medical- Key Events Impacting Share Price Performance
Table 4: BioMS Medical- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 5: BioMS Medical- Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 6: BioMS Medical- Balance Sheet
Table 7: BioMS Medical- Cash Flow
Table 8: BioMS Medical- Collaboration Products
Table 9: BioMS Medical- Forecast Sales, 2006-2010 ($ Mn)
Table 10: BioMS Medical- Key Competitors
Table 11: BioMS Medical- Key Suppliers
Table 12: BioMS Medical- SWOT Analysis Summary
Table 13: BioMS Medical- Value Chain Analysis
Table 14: BioMS Medical- Key Employees
Table 15: BioMS Medical - Financial and Operational Overview


Abstract

Introduction

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

BioMS Medical’s lead candidate MBP8298 was licensed from University of Alberta. In addition, the company also licensed two technology platforms from the University of Alberta. One technology, HYC750, relates to the delivery of anti-viral and chemotherapy drugs into cells for the purpose of improving the effectiveness of those drugs. The other technology relates to the imaging of genes that have been delivered into cells as part of gene therapy treatment. Both technologies are at an early stage of development. BioMS Medical expects to increase its revenues from $81 million in 2008 to $134 million in 2010, primarily from the licensing and development agreement with Eli Lilly. As per the agreement, BioMS Medical would receive upfront payment in 2008.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization .

Please note: This is delivered as a Zip file.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008